Drug Trial Radar · NCT00925275
Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors
Last checked: Nov 19, 2026Latest source record: May 4, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
9
Planned (sponsor's estimate)
Start
Jun 2009
Primary completion
Feb 2010
Study completion Feb 2010
Sponsor
- Lead sponsor
- Cellectar, IncIndustry
- Sponsor type
- Industry
- First posted
- Jun 22, 2009
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to investigate the safety, biodistribution, radiation dosimetry and pharmacokinetics of I-131-CLR1404.
Conditions
- Solid Tumors
Interventions
I-131-CLR1404Drug
Single intravenous injection of 10 millicuries of I-131-CLR1404 given on Day 0
Primary outcomes
What the sponsor says the trial is designed to measure.
- Calculate whole body and organ radiation dosimetry of I-131-CLR1404 to determine the millicurie dose which is expected to deliver 35-40 centigray of radiation to bone marrowTime frame: 42 days
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
City of Hope
Duarte, California
Georgetown University, Lombardi Cancer Center
Washington D.C., District of Columbia
Johns Hopkins University School of Medicine
Baltimore, Maryland
Duke University Medical Center
Durham, North Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.